Table 2 Clinical profiles of HBV-infected patients and healthy controls
Clinical characteristics | Patients (n = 473) | Controls (n = 238) |
|---|---|---|
Age (years) | 51 (18–90) | 30 (18–55) |
Male/Female | 420/53 | 159/79 |
HBsAg | Positive | Negative |
Anti-HCV | Negative | Negative |
Anti-HIV | Negative | Negative |
AFP (IU/mL) | 11.78 (0.8–400) | <  5 |
HBV DNA (copies/mL) | 269,408 (100–11,300,000,000) | NA |
WBC (×103/mL) | 6.4 (1.8–20.5) | NR |
RBC (× 106/mL) | 4.1 (1.9–7.43) | NR |
PLT (×103/mL) | 157 (6.7–641) | NR |
AST (IU/mL) | 90 (16–7700) | NR |
ALT (IU/mL) | 61.25 (4–4908) | NR |
Total Bilirubin (umol/mL) | 20.7 (5.7–733) | NR |
Direct Bilirubin (umol/mL) | 6.7 (1–450) | NR |
Albumin (g/L) | 38.7 (16–54) | ND |
Prothrombin (% of standard) | 85 (14–267) | ND |
Vitamin D levels (ng/ml) | 20.42 (6.4–64.4) | 20 (11.6–85.6) |